Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mocroft

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
HIV Medicine|December 12, 2001
Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97A Mocroft, C A Sabin, M Youle, et al.
HIV Medicine|April 11, 2008
Loss to follow-up in an international, multicentre observational studyA Mocroft, O Kirk, P Aldins, et al.
HIV Medicine|September 4, 2010
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA studyJ Reekie, P Reiss, B Ledergerber, et al.
HIV Medicine|October 28, 2016
Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individualsD Grint, E Tedaldi, L Peters, et al.
AIDS (London, England)|September 8, 2001
Reduced bone mineral density in HIV-positive individualsA L Moore, A Vashisht, C A Sabin, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JDO Kirk, J M Gatell, A Mocroft, et al.
HIV Medicine|May 13, 2014
High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearanceL Peters, A Mocroft, V Soriano, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
HIV Medicine|March 6, 2010
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment changeJ Reekie, A Mocroft, B Ledergerber, et al.
AIDS (London, England)|August 13, 2002
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA studyA Mocroft, R Brettle, O Kirk, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
HIV Medicine|December 12, 2001
Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97A Mocroft, C A Sabin, M Youle, et al.
HIV Medicine|April 11, 2008
Loss to follow-up in an international, multicentre observational studyA Mocroft, O Kirk, P Aldins, et al.
HIV Medicine|September 4, 2010
A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA studyJ Reekie, P Reiss, B Ledergerber, et al.
HIV Medicine|October 28, 2016
Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individualsD Grint, E Tedaldi, L Peters, et al.
AIDS (London, England)|September 8, 2001
Reduced bone mineral density in HIV-positive individualsA L Moore, A Vashisht, C A Sabin, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2000
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JDO Kirk, J M Gatell, A Mocroft, et al.
HIV Medicine|May 13, 2014
High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearanceL Peters, A Mocroft, V Soriano, et al.
Lancet (London, England)|July 31, 2007
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyA Mocroft, A N Phillips, J Gatell, et al.
HIV Medicine|March 6, 2010
History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment changeJ Reekie, A Mocroft, B Ledergerber, et al.
AIDS (London, England)|August 13, 2002
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA studyA Mocroft, R Brettle, O Kirk, et al.
Pageof 12